BPC-157
A gastric pentadecapeptide that accelerates tissue repair and gut healing.
From $199/mo
How It Works
BPC-157 exerts its healing effects through multiple convergent pathways. It upregulates vascular endothelial growth factor (VEGF) receptor expression, promoting angiogenesis and restoring blood supply to damaged tissues. It modulates the nitric oxide (NO) system, maintaining vascular homeostasis and reducing ischemia-reperfusion injury. BPC-157 interacts with the dopamine, serotonin, and GABAergic systems, which may explain its protective effects on the central and enteric nervous systems. At the cellular level, it promotes fibroblast proliferation and migration, accelerates collagen organization, and enhances tendon-to-bone healing by upregulating growth hormone receptor expression. In the GI tract, it stabilizes the mucosal barrier, promotes epithelial cell proliferation, and counteracts lesions induced by NSAIDs, alcohol, and stress.
Key Benefits
Clinical Research
BPC-157 has been studied in over 100 preclinical publications. In rat models, it significantly accelerated Achilles tendon healing (Staresinic et al., 2003), with treated tendons showing 70% greater breaking force at 14 days compared to controls. Gastrointestinal studies demonstrated protection against ethanol-induced, NSAID-induced, and stress-induced gastric lesions with rapid mucosal healing (Sikiric et al., 1993-2018). Muscle healing studies showed faster recovery of crushed gastrocnemius muscle with improved functional outcomes (Chang et al., 2011). Ligament healing research demonstrated enhanced MCL repair with more organized collagen structure (Chang et al., 2014). While human clinical trials are limited, a Phase 2 trial for inflammatory bowel disease (PL 14736) showed promising results for ulcerative colitis. The breadth and consistency of preclinical data strongly support its tissue-protective properties.
Dosage & Administration
Dosage
Typical dosing protocols range from 250 mcg to 500 mcg administered once or twice daily. For acute injuries, a common protocol is 500 mcg twice daily (morning and evening) for 4-8 weeks. For gastrointestinal support, 250-500 mcg once daily is typical. Some protocols include oral administration for GI-targeted effects. Your GetPepWell physician will determine the appropriate dose and duration based on your specific condition and treatment goals. Cycling protocols (e.g., 4 weeks on, 2 weeks off) may be recommended for long-term use.
Administration
BPC-157 can be administered via subcutaneous injection or orally. For musculoskeletal injuries, subcutaneous injection near the injury site is preferred as it delivers higher local concentrations. Injections use a 29-31 gauge insulin syringe. For gastrointestinal applications, oral administration (capsule form) is effective as BPC-157 is stable in gastric acid, which is unusual for peptides. Some patients combine both routes - oral for gut healing and injection for musculoskeletal repair. Injection sites should be cleaned with an alcohol swab before administration.
Side Effects
- Generally very well-tolerated in published research
- Mild injection site discomfort or redness
- Occasional lightheadedness shortly after injection
- Mild nausea (more common with oral administration)
- Temporary fatigue in some individuals
Contra-indications
- Known hypersensitivity to BPC-157 or any excipients
- Active cancer or history of cancer (due to angiogenesis promotion)
- Pregnancy or breastfeeding
- Children under 18 years of age
- Patients on active anticoagulation therapy (consult physician)
Drug Interactions
- Anticoagulants (warfarin, heparin) - may influence wound healing dynamics
- NSAIDs - BPC-157 may counteract GI damage but interaction with therapeutic effects is unstudied in humans
- Growth hormone or growth hormone secretagogues - potential additive effects on tissue growth; monitor closely
Storage Info
Store lyophilized (powder) form refrigerated at 36-46 degrees F (2-8 degrees C). After reconstitution with bacteriostatic water, store refrigerated and use within 30 days. Do not freeze reconstituted solution. Protect from light. Oral capsules should be stored at room temperature in a cool, dry place away from moisture and direct sunlight.
BPC-157 FAQ
Find answers to the most common questions about this treatment.
Related Products
Interested in BPC-157?
Schedule a consultation with a licensed physician to see if this treatment is right for you.